About Batavia Biosciences
Batavia Biosciences is a Healthcare company based in Leiden (Netherlands) founded in 2010 by Chris Yallop and Menzo Havenga, and was acquired by CJ CheilJedang in November 2021. Biologics CDMO offering proprietary process development technologies for the development of recombinant proteins, vaccines and gene therapy products. The company has 11 employees. Its chief executive, as recorded, is Menzo Havenga. Batavia Biosciences offers products and services including Viral Vectors, Viral Vaccines, and HIP-Vax Technology. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity is BATAVIA BIO PROCESSING LIMITED.
Company details
Batavia Biosciences is a CDMO engaged in the development of biopharmaceutical products such as proteins, antibodies, vaccines and viral vectors. They have a portfolio of technologies for improving product yield (STEP), to reduce process development time (SIDUS, SCOUT) and for improving product stability. Their STEP technology is a plasmid based expression platform that enables rapid mammalian CHO cell line generation and improved protein expression. Batavia claims that the STEP platform can offer up to 10-fold increase in protein expression and the stable cell clones can be generated in 14 weeks. They also have a transient production technology that can be used for producing clinical material (proteins) faster. The company claims to have expertise in upstream (mammalian, microbial and insect based platforms) and downstream processing, clinical and commercial manufacturing and also in DNA cloning and mammalian cell line generation.
- Headquarters Leiden, Netherlands
- Employees 11
- Founders Chris Yallop, Menzo Havenga
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailโขโขโขโขโขโขโขโข
- Website bataviabiosciences.com
- Social LinkedIn X
- Acquired by CJ CheilJedang (Nov 2021)
- Legal Name Batavia Bio Processing Limited
- Latest Funding Round$444.29K (USD), Grant
May 2023
- InvestorsGates Foundation
& 3 more
- Employee Count11
- Acquired byCJ CheilJedang
(Nov 2021)
Products & Services of Batavia Biosciences
Batavia Biosciences offers a comprehensive portfolio of products and services, including Viral Vectors, Viral Vaccines, and HIP-Vax Technology.
Development and manufacturing for gene therapy and delivery tools.
Process development for vaccine production and applications.
Platform for efficient polio and other vaccine manufacturing processes.
Funding Insights of Batavia Biosciences
- Total Rounds 8
- Last Round Grant โ $444,292
- First Round $12M
(Jun 2016)
- Investors Count 3
All 8 funding rounds of Batavia Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $444,292 | Grant | โ | โ | |
| Sep 2019 | $6.5M | Grant | โ | โ | |
| Jul 2019 | $2.2M | Grant | โ | โ | |
| Feb 2019 | $13.2M | Grant | โ | โ | |
| Jan 2019 | $889,938 | Grant | โ | โ | |
| Jan 2018 | $1.18M | Grant | โ | โ | |
| Jan 2018 | $4M | Grant | โ | โ | |
| Jun 2016 | $12M | Grant | โ | โ |
4 investors in total: 4 institutional.
Investors in Batavia Biosciences
Batavia Biosciences has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, Path and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Global health solutions are developed and delivered to enhance outcomes. | 1977 | path.org | United States | |
CJ CheilJedang is engaged in food and bio industries. | cj.co.kr | Seoul, South Korea |
Investor details for Batavia Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Batavia Biosciences
31 people are tracked at Batavia Biosciences (11 in leadership, 20 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Chris Yallop | Co-Founder | Leadership |
Menzo Havenga | CEO & Founder | Leadership |
Marty Stork | Chief Human Resources Officer | Leadership |
Jeffrey Kovacs | Head Of BD - US | Leadership |
David Foster | Chief Scientific Officer | Leadership |
Pablo Mendes de León | CFO | Leadership |
Ingrid van Aarle | Human Resources Director | Leadership |
Pieter-Jan Vos | Director Business Development | Leadership |
Marieke Willemsen | Project Director | Leadership |
Wendy Laird | Director, Business Development | Leadership |
Carola Jüstel | Senior Director Business Development | Leadership |
Fiona Hancox | Functional Support Technician | Team |
Jordy K. | QC Specialist | Team |
Fouad El Khayari | Quality Assurance Officer | Team |
Annemiek Hildebrand-Bosman | QA Manager | Team |
Assia Bouabda | QA Officer | Team |
Hans Verdurmen | Scientist USP Process Development | Team |
Jochem Pronk | Sr. Scientist DSP | Team |
A. Mecit Gokce | Senior Scientist | Team |
David Mourette | Business Controller | Team |
11 more people are available in the full profile.
Complete people profiles for Batavia Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Batavia Biosciences
4 dated milestones of Batavia Biosciences across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Batavia Biosciences is founded.
- Funding First funding round of $12.0M.
- Exit Acquired by CJ CheilJedang.
- Funding Latest funding round, Grant, of $444K.
Web traffic of Batavia Biosciences
The website of Batavia Biosciences (bataviabiosciences.com) receives about 6.8K visits a month and ranks #3,268,559 among all websites worldwide, #4,297 in Biotechnology and Pharmaceuticals.
- Monthly visits6.8K
▲ 8.8% vs previous month
- Unique visitors2.6K
per month
- Global rank#3,268,559
among all websites
- Category rank#4,297
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.6
- Average visit9 sec
- DevicesDesktop 42% ยท Mobile 58%
Websites whose visitors overlap most with Batavia Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| astellas.com | 100% | 170.7K | #288,207 | View details | |
| interpulse.nl | 36% | #8,540,819 | View details | ||
| vicotx.com | 36% | 2.5K | #6,930,770 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track โ from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Batavia Biosciences
Complete news archive for Batavia Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Batavia Biosciences
Batavia Biosciences was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Batavia Biosciences is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Menzo Havenga is the CEO of Batavia Biosciences, as recorded in our data. They have also founded this company.
Batavia Biosciences has 11 employees.
Batavia Biosciences is a CDMO engaged in the development of biopharmaceutical products such as proteins, antibodies, vaccines and viral vectors. They have a portfolio of technologies for improving product yield (STEP), to reduce process development time (SIDUS, SCOUT) and for improving product stability. Their STEP technology is a plasmid based expression platform that enables rapid mammalian CHO cell line generation and improved protein expression. Batavia claims that the STEP platform can offer up to 10-fold increase in protein expression and the stable cell clones can be generated in 14 weeks. They also have a transient production technology that can be used for producing clinical material (proteins) faster. The company claims to have expertise in upstream (mammalian, microbial and insect based platforms) and downstream processing, clinical and commercial manufacturing and also in DNA cloning and mammalian cell line generation.
Batavia Biosciences offers Viral Vectors, Viral Vaccines, and HIP-Vax Technology.
Batavia Biosciences has 4 investors. Key investors include Gates Foundation, Path, European Union, and CJ CheilJedang.
Batavia Biosciences operates through Batavia Bio Processing Limited.
Yes. Batavia Biosciences was acquired by CJ CheilJedang in November 2021.

